15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Surrozen Inc, 3 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $40.00 to $44.00, so the covering firms are broadly aligned. The average target of $42.00 sits 114% above the current $19.66. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-1.29 next quarter toward $-3.98 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Surrozen Inc.
As of Jul, 3 of 3 firms rate SRZN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
SRZN EPS & revenue forecast
EPS · NEXT QUARTER
$-1.29
Range $-1.40 – $-1.19 · 2 analysts · -64% YoY
Next period, 2 analysts expect Surrozen Inc to earn $-1.29 a share (range $-1.40 – $-1.19), versus $-3.60 a year earlier. Full-year consensus is $-3.70, growing to $-3.98 the year after.
REVENUE · NEXT QUARTER
$869.0K
Range $869.0K – $869.0K · 2 analysts · -12% YoY
Revenue is expected to reach $869.0K (range $869.0K – $869.0K), -11.6% year-over-year. Full-year consensus is $5.9M, rising to $3.5M next year.
Top analysts covering Surrozen Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on SRZN.
#1
Yatin Suneja
Guggenheim · Rank #28
Buy
$45.00+128.9% to target
Overall win rate
52%
+ Follow
#2
MC
Matthew Caufield
HC Wainwright & Co. · Rank #51
Buy
$44.00+123.8% to target
Overall win rate
56%
+ Follow
#3
SS
Steve Seedhouse
Cantor Fitzgerald
Buy
$40.00+103.5% to target
Coverage
—
+ Follow
#4
Phil Nadeau
TD Cowen
Buy
No targeton SRZN
Coverage
—
+ Follow
#5
Steven Seedhouse
Cantor Fitzgerald
Buy
$40.00+103.5% to target
Coverage
—
+ Follow
SRZN stock forecast FAQ
What is SRZN's average 12-month price target?+
The 2 analysts with a live target average $42.00 for Surrozen Inc over the next 12 months, ranging from a $44.00 high to a $40.00 low.
Is SRZN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for SRZN?+
The Street-high target is $44.00 (HC Wainwright & Co.), and the Street-low is $40.00 (Cantor Fitzgerald). The average of all 2 active targets is $42.00.
How many Wall Street analysts cover SRZN?+
3 analysts have an active rating on Surrozen Inc, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering SRZN?+
Among analysts who currently cover SRZN, Yatin Suneja of Guggenheim has the strongest overall Quantellect track record (Rank #28). Their current call is Buy with a $45.00 target.
What is Surrozen Inc's projected EPS for next quarter?+
The consensus estimate is $-1.29 per share (range $-1.40 – $-1.19) across 2 analysts. Full-year EPS is projected at $-3.70, rising to $-3.98 the following year.
How much revenue is Surrozen Inc expected to report next quarter?+
Consensus revenue is $869.0K (range $869.0K – $869.0K). Full-year revenue is projected at $5.9M, growing to $3.5M next year.
Have analysts been upgrading or downgrading SRZN lately?+
As of Jul, 3 of 3 firms rate SRZN a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their SRZN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
